RENAL FUNCTION IN PATIENTS WITH GOUT.
作者信息
Coombs F S, Pecora L J, Thorogood E, Consolazio W V, Talbott J H
机构信息
Medical Clinic of the Massachusetts General Hospital, Boston.
出版信息
J Clin Invest. 1940 May;19(3):525-35. doi: 10.1172/JCI101156.
Abstract
摘要
相似文献
1
RENAL FUNCTION IN PATIENTS WITH GOUT.
J Clin Invest. 1940 May;19(3):525-35. doi: 10.1172/JCI101156.
2
Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts.
Nephron. 2000 Nov;86(3):287-91. doi: 10.1159/000045783.
3
Renal function in gout patients.
Am J Nephrol. 1995;15(1):31-7. doi: 10.1159/000168799.
4
Uric acid fluctuation had no effect on renal function among gout patients.
Nutr Metab Cardiovasc Dis. 2020 Sep 24;30(10):1833-1839. doi: 10.1016/j.numecd.2020.06.008. Epub 2020 Jun 20.
5
Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.
Arthritis Rheumatol. 2016 Aug;68(8):2035-43. doi: 10.1002/art.39654.
6
Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease.
Am J Med. 1982 Jan;72(1):95-100. doi: 10.1016/0002-9343(82)90593-9.
7
Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo-Controlled Study.
Arthritis Rheumatol. 2019 Jan;71(1):143-153. doi: 10.1002/art.40685.
8
Treatment of gout patients with impairment of renal function: a systematic literature review.
J Rheumatol Suppl. 2014 Sep;92:48-54. doi: 10.3899/jrheum.140462.
9
An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.
PLoS One. 2018 Feb 28;13(2):e0193622. doi: 10.1371/journal.pone.0193622. eCollection 2018.
10
Managing Gout in the Patient with Renal Impairment.
Drugs Aging. 2018 Apr;35(4):263-273. doi: 10.1007/s40266-018-0517-7.
引用本文的文献
1
Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis.
Front Pharmacol. 2024 Mar 26;15:1373258. doi: 10.3389/fphar.2024.1373258. eCollection 2024.
2
Uric Acid and Chronic Kidney Disease: Still More to Do.
Kidney Int Rep. 2022 Dec 5;8(2):229-239. doi: 10.1016/j.ekir.2022.11.016. eCollection 2023 Feb.
3
Public Health Weekly Reports for AUGUST 28, 1942.
Public Health Rep (1896). 1942 Aug 28;57(35):1287-1326.
4
The Treatment of Gout.
Bull N Y Acad Med. 1942 May;18(5):318-28.
5
Uric acid and cardiovascular risk.
N Engl J Med. 2008 Oct 23;359(17):1811-21. doi: 10.1056/NEJMra0800885.
6
Review of Gout, 1939-1946.
Ann Rheum Dis. 1946 Sep;5(5):171-6. doi: 10.1136/ard.5.5.171.
7
IMPAIRMENT OF URIC ACID EXCRETION IN GOUT.
J Clin Invest. 1962 Nov;41(11):1955-63. doi: 10.1172/JCI104653.
8
THE RENAL EXCRETION OF URIC ACID IN GOUT.
J Clin Invest. 1962 May;41(5):1094-8. doi: 10.1172/JCI104560.
9
THE EFFECT OF DIODRAST ON THE NORMAL URIC ACID CLEARANCE.
J Clin Invest. 1944 Sep;23(5):776-82. doi: 10.1172/JCI101550.
10
RENAL FUNCTION IN PATIENTS WITH ADDISON'S DISEASE AND IN PATIENTS WITH ADRENAL INSUFFICIENCY SECONDARY TO PITUITARY PAN-HYPOFUNCTION.
J Clin Invest. 1942 Jan;21(1):107-19. doi: 10.1172/JCI101272.
本文引用的文献
1
EXPERIMENTAL HYPOSTHENURIA.
J Clin Invest. 1939 Mar;18(2):195-212. doi: 10.1172/JCI101035.
2
THE CONTROL OF RENAL BLOOD FLOW AND GLOMERULAR FILTRATION IN NORMAL MAN.
J Clin Invest. 1938 Sep;17(5):683-97. doi: 10.1172/JCI100996.
3
THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEY.
J Clin Invest. 1938 May;17(3):263-78. doi: 10.1172/JCI100950.
4
THE ELECTROLYTE BALANCE IN ACUTE GOUT.
J Clin Invest. 1935 Jul;14(4):411-21. doi: 10.1172/JCI100692.
5
THE EXCRETION OF INULIN, XYLOSE AND UREA BY NORMAL AND PHLORIZINIZED MAN.
J Clin Invest. 1935 Jul;14(4):393-401. doi: 10.1172/JCI100690.
Zotero 插件